Wall Street ends mixed, healthcare and energy stocks weigh on S&P
The Economic Times· 2025-12-17 01:54
A separate report on Tuesday showed retail sales were flat in October, just below an estimate of economists polled by Reuters calling for a rise of 0.1%. Analysts flagged the likelihood of the figures being distorted by slow data collection due to a recent government shutdown."This is all fairly old news at this point. Most data points are being viewed in the lens of what they are going to do to the Fed, and the data you got today isn't likely to move the needle," said Mark Hackett, chief market strategist ...
RWTQ: A 9.50% Senior Note IPO From Redwood Trust (NYSE:RWT)
Seeking Alpha· 2025-12-17 01:53
Group 1 - The article focuses on monitoring newly listed fixed-income securities on the exchange, specifically highlighting Redwood Trust's (RWT) latest Arbitrage Trader [1] - Denislav Iliev, with over 15 years of day trading experience, leads a team of 40 analysts who identify mispriced investments in fixed-income and closed-end funds [1] - The investing group Trade With Beta offers features such as frequent picks for mispriced preferred stocks and baby bonds, weekly reviews of over 1200 equities, IPO previews, hedging strategies, and an actively managed portfolio [1]
QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Prnewswire· 2025-12-17 01:53
Core Points - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of investors of uniQure N.V. [1] - On November 3, 2025, uniQure announced that the FDA indicated insufficient evidence from its AMT-130 gene therapy studies to support a Biologics License Application (BLA) [2] - Following this announcement, uniQure's stock price dropped over 50%, from $67.69 on October 31, 2025, to $34.29 on November 3, 2025 [3] Company Summary - uniQure N.V. is focused on developing gene therapies, specifically for conditions like Huntington's disease [2] - The company is currently facing challenges regarding the regulatory approval process for its investigational therapy AMT-130 [2] Legal and Regulatory Context - The investigation by Kessler Topaz Meltzer & Check, LLP highlights potential legal implications for uniQure related to securities laws [1] - The FDA's feedback on the adequacy of clinical trial data for AMT-130 raises concerns about the company's future regulatory submissions [2]
JHX Investor Deadline Alert: James Hardie (JHX) Class Action Lawsuit — Hagens Berman Scrutinizing Alleged Inventory Destocking and 34% Plunge; December 23 Lead Plaintiff Deadline Looms
Globenewswire· 2025-12-17 01:51
Core Viewpoint - A securities class action lawsuit has been filed against James Hardie Industries plc, alleging that the company and its executives made materially false and misleading statements regarding the health of its North America Fiber Cement segment, leading to a significant stock drop of over 34% when the truth was revealed [2][5]. Summary by Sections Lawsuit Allegations - The lawsuit claims that James Hardie executives misled investors by asserting that the North America segment was strong and that distributor inventory levels were normal, despite knowing that distributors were aggressively destocking inventory [3][4]. - Management allegedly inflated sales figures by loading inventory rather than reflecting genuine demand, using terms like "robust" and "normal" to describe the market conditions [4]. Timeline and Key Details - Class Period: May 20, 2025 – August 18, 2025 - Lead Plaintiff Deadline: December 23, 2025 - Stock Drop: The stock fell over 34% on August 20, 2025, following the disclosure of a 12% decline in North America sales due to customer destocking [5]. Next Steps for Investors - Investors who purchased James Hardie stock during the class period and experienced substantial losses are encouraged to contact Hagens Berman to discuss legal options and potential appointment as Lead Plaintiff [6].
Crypto exchange HashKey shares end flat in volatile Hong Kong trading debut
Yahoo Finance· 2025-12-17 01:47
By Kane Wu, Scott Murdoch and Donny Kwok HONG KONG, Dec 17 (Reuters) - Cryptocurrency exchange HashKey Holdings Ltd made a flat debut in Hong Kong on Wednesday amid recent weakness in digital assets, but its management said it remains confident about the sector's long-term prospects. HashKey shares closed at HK$6.67, down 0.15% from the offer price of HK$6.68. The stock rose as much as 6.6% to HK$7.12 before sliding 8.4% to an intraday low of HK$6.12. That compared with a 0.9% gain in the benchmark Ha ...
US orders unit at TransAlta coal plant in Washington state to stay open
Reuters· 2025-12-17 01:38
Core Viewpoint - The U.S. energy secretary's order to keep a unit of the TransAlta coal power plant operational through winter reflects the Trump administration's ongoing support for fossil fuels [1] Group 1 - The order was signed on Tuesday, indicating a timely response to energy needs during the winter season [1] - The decision to maintain operations at the TransAlta coal power plant highlights the administration's policy direction favoring traditional energy sources over renewable alternatives [1]
Asian Currencies Consolidate; Fed Rate-Cut Prospects May Support
WSJ· 2025-12-17 01:33
Core Insights - Asian currencies have shown consolidation against the US dollar, indicating a potential stabilization in the region's currency markets [1] - The prospect of Federal Reserve rate cuts may provide support for Asian currencies, suggesting a favorable outlook for currency performance [1] Currency Market Analysis - The consolidation of Asian currencies against the dollar reflects a broader trend in the foreign exchange market [1] - Potential rate cuts by the Federal Reserve could lead to increased investor confidence in Asian currencies, enhancing their attractiveness [1]
3 Fidelity ETFs You Can Buy and Hold Forever to Generate $100,000 in Yearly Dividend Income, Starting in 2026
The Motley Fool· 2025-12-17 01:30
Core Viewpoint - Dividend-paying stocks provide three avenues for profit: capital appreciation, cash dividends, and increasing payouts over time, making them attractive investments [2]. Group 1: Overview of Dividend-Focused ETFs - Fidelity offers three notable dividend-focused ETFs that have outperformed the S&P 500 while providing higher dividend yields [1][3]. - The ETFs are designed to reflect the performance of dividend-paying companies, focusing on both growth and income [7]. Group 2: Performance and Key Metrics - Fidelity High Dividend ETF (FDVV) has a recent dividend yield of 3.02% and a 5-year average annual return of 16.34% [6][7]. - Fidelity International High Dividend ETF (FIDI) boasts a higher dividend yield of 4.30% and has performed well due to a weakening dollar [10][11]. - Fidelity Total Bond ETF (FBND) offers a dividend yield of 4.60%, focusing on diversification through bonds [13][14]. - Vanguard S&P 500 ETF (VOO) has a lower dividend yield of 1.12% but is included for comparison with the Fidelity offerings [15]. Group 3: Investment Requirements - To generate $100,000 in annual dividends from FDVV, an investment of approximately $3.125 million is needed [9]. - For FIDI, an investment of about $2.3 million is required to achieve the same annual dividend income [12]. - The Total Bond ETF requires around $2.18 million for $100,000 in annual dividends [14]. - The Vanguard S&P 500 ETF necessitates over $8 million for the same dividend income target [15].
HashKey shares start trading in Hong Kong, as the city increasingly embraces crypto
Yahoo Finance· 2025-12-17 01:30
Shares of digital assets firm Hashkey Holdings were flat in Hong Kong trading today, following the firm’s IPO last week. The Chinese city has steadily embraced digital assets since 2022 as it tries to maintain its status as a global financial center. The crypto firm’s shares ended the day 0.2% lower in a choppy day of trading, with a post-opening surge, followed by a slump for most of the day before recovering right before market close. Hashkey, founded in 2018, operates a Hong Kong-licensed crypto excha ...
Oil Rises on Likely Technical Recovery
WSJ· 2025-12-17 01:28
Core Viewpoint - Oil prices increased during Asia's morning session, indicating a potential technical recovery after oil futures had previously dropped to nearly five-year lows overnight [1] Group 1 - Oil futures experienced a significant decline, reaching levels not seen in almost five years [1] - The rise in oil prices during the morning session suggests a possible rebound in the market [1]